CU6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clarity Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price on Oct 14: 1.825 AUD

Market Cap: AU$680.9m

Prices of ASX stocks are not being updated. The latest CU6 price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.

C	Clarity Pharmaceuticals Ltd ASX:CU6	AU
	Root Inc NASDAQ:ROOT	US
	Orient Corp F:OIT	JP

Profitability Summary

Clarity Pharmaceuticals Ltd's profitability score is 4/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-277%

Low Net Margin

Negative 3Y Average Net Margin

-259%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-323%

Negative ROE

-78%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-418%

Declining ROIC

-387% > -704%

View All

Hide

Collapse

4 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.